These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28160502)

  • 1. Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells.
    Kim D; Hong A; Park HI; Shin WH; Yoo L; Jeon SJ; Chung KC
    J Cell Physiol; 2017 Dec; 232(12):3664-3676. PubMed ID: 28160502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth.
    Atanassov BS; Mohan RD; Lan X; Kuang X; Lu Y; Lin K; McIvor E; Li W; Zhang Y; Florens L; Byrum SD; Mackintosh SG; Calhoun-Davis T; Koutelou E; Wang L; Tang DG; Tackett AJ; Washburn MP; Workman JL; Dent SY
    Mol Cell; 2016 May; 62(4):558-71. PubMed ID: 27132940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway.
    Liu YL; Jiang SX; Yang YM; Xu H; Liu JL; Wang XS
    Cell Biochem Biophys; 2012 Jan; 62(1):229-35. PubMed ID: 21928107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deubiquitinating enzyme activity of USP22 is necessary for regulating HeLa cell growth.
    Liu YL; Zheng J; Tang LJ; Han W; Wang JM; Liu DW; Tian QB
    Gene; 2015 Nov; 572(1):49-56. PubMed ID: 26143114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex.
    Yang H; Liu S; He WT; Zhao J; Jiang LL; Hu HY
    J Biol Chem; 2015 Sep; 290(36):21996-2004. PubMed ID: 26195632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells.
    Gennaro VJ; Stanek TJ; Peck AR; Sun Y; Wang F; Qie S; Knudsen KE; Rui H; Butt T; Diehl JA; McMahon SB
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9298-E9307. PubMed ID: 30224477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
    Liu YL; Yang YM; Xu H; Dong XS
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-specific peptidase USP22 negatively regulates the STAT signaling pathway by deubiquitinating SIRT1.
    Ao N; Liu Y; Feng H; Bian X; Li Z; Gu B; Zhao X; Liu Y
    Cell Physiol Biochem; 2014; 33(6):1863-75. PubMed ID: 24969755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest.
    Ling SB; Sun DG; Tang B; Guo C; Zhang Y; Liang R; Wang LM
    Cell Mol Biol (Noisy-le-grand); 2012 Dec; 58 Suppl():OL1803-8. PubMed ID: 23217440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.
    Zhuang YJ; Liao ZW; Yu HW; Song XL; Liu Y; Shi XY; Lin XD; Zhou TC
    Cancer Biol Ther; 2015; 16(1):88-96. PubMed ID: 25482932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1.
    Atanassov BS; Dent SY
    EMBO Rep; 2011 Sep; 12(9):924-30. PubMed ID: 21779003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-specific protease 22 (USP22) positively regulates RCAN1 protein levels through RCAN1 de-ubiquitination.
    Hong A; Lee JE; Chung KC
    J Cell Physiol; 2015 Jul; 230(7):1651-60. PubMed ID: 25546086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer.
    Xiao H; Tian Y; Yang Y; Hu F; Xie X; Mei J; Ding F
    Biochem Biophys Res Commun; 2015 May; 460(3):703-8. PubMed ID: 25817787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
    Li J; Gao R; Zhang J
    Clin Breast Cancer; 2023 Feb; 23(2):162-175. PubMed ID: 36528490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin hydrolase USP22 contributes to 3'-end processing of JAK-STAT-inducible genes.
    Chipumuro E; Henriksen MA
    FASEB J; 2012 Feb; 26(2):842-54. PubMed ID: 22067483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling.
    Liu H; Liu N; Zhao Y; Zhu X; Wang C; Liu Q; Gao C; Zhao X; Li J
    Aging (Albany NY); 2019 Nov; 11(21):9643-9660. PubMed ID: 31689236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma.
    Zhang H; Han B; Lu H; Zhao Y; Chen X; Meng Q; Cao M; Cai L; Hu J
    Cancer Lett; 2018 Oct; 433():186-198. PubMed ID: 29981430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex.
    Armour SM; Bennett EJ; Braun CR; Zhang XY; McMahon SB; Gygi SP; Harper JW; Sinclair DA
    Mol Cell Biol; 2013 Apr; 33(8):1487-502. PubMed ID: 23382074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tightly controlled deubiquitination activity of the human SAGA complex differentially modifies distinct gene regulatory elements.
    Lang G; Bonnet J; Umlauf D; Karmodiya K; Koffler J; Stierle M; Devys D; Tora L
    Mol Cell Biol; 2011 Sep; 31(18):3734-44. PubMed ID: 21746879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth.
    Xu H; Liu YL; Yang YM; Dong XS
    Int J Colorectal Dis; 2012 Jan; 27(1):21-30. PubMed ID: 21773699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.